Who is using Auvelity for depression?
Video Journal of Biomedicine December 17, 2025 A. Muzyk, F. Syed, Junjun Cong et al.
Abstract This study is the first to analyse real-world use of Auvelity (dextromethorphan HBr and bupropion HCL, 45 mg/105 mg extended-release tablets) for treating major depressive disorder (MDD) in the United States. Researchers reviewed medical records of over 22,000 adults, examining factors like age, gender, insurance, and previous depression treatments. Findings revealed that patients...